Literature DB >> 10877840

Putative role of neuronal 5-lipoxygenase in an aging brain.

H Manev1, T Uz, K Sugaya, T Qu.   

Abstract

Aging is associated with increased incidence and/or severity of neurodegenerative pathologies. Oxygen-mediated events are being considered as possible mechanisms responsible for the increasing neuronal vulnerability. Lipoxygenases are enzymes that, as cyclooxygenases (COX), can insert oxygen into the molecule of arachidonic acid and thereby synthesize inflammatory eicosanoids: leukotrienes [due to 5-lipoxygenase (5-LOX) activity] and prostaglandins (via COX activity). It appears that 5-LOX is expressed in central nervous system neurons and may participate in neurodegeneration. 5-LOX-triggered cell death may be initiated by the enzymatic activity of 5-LOX but could also occur via the nonenzymatic actions of the 5-LOX protein; new data point to the possibility that 5-LOX protein exerts actions such as interaction with tyrosine kinase receptors, cytoskeletal proteins, and the nucleus. The expression of neuronal 5-LOX is susceptible to hormonal regulation, presumably due to the presence of hormone-responsive elements in the structure of the 5-LOX gene promoter. The expression of the 5-LOX gene and the activity of the 5-LOX pathway are increased in elderly subjects. One possible mechanism of such 5-LOX up-regulation implies the contribution of aging-associated hormonal changes: relative melatonin deficiency and/or hyperglucocorticoidemia. Thus, the 5-LOX pathway could become a promising target of neuroprotective therapies for the aging brain.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10877840     DOI: 10.1096/fj.14.10.1464

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  22 in total

Review 1.  The role of gonadotropins in Alzheimer's disease: potential neurodegenerative mechanisms.

Authors:  Anna M Barron; Giuseppe Verdile; Ralph N Martins
Journal:  Endocrine       Date:  2006-04       Impact factor: 3.633

2.  Increased 5-lipoxygenase immunoreactivity in the hippocampus of patients with Alzheimer's disease.

Authors:  Milos D Ikonomovic; Eric E Abrahamson; Tolga Uz; Hari Manev; Steven T Dekosky
Journal:  J Histochem Cytochem       Date:  2008-08-04       Impact factor: 2.479

Review 3.  Intersection between metabolic dysfunction, high fat diet consumption, and brain aging.

Authors:  Romina M Uranga; Annadora J Bruce-Keller; Christopher D Morrison; Sun Ok Fernandez-Kim; Philip J Ebenezer; Le Zhang; Kalavathi Dasuri; Jeffrey N Keller
Journal:  J Neurochem       Date:  2010-05-06       Impact factor: 5.372

4.  Genome-wide analysis of lipoxygenase gene family in Arabidopsis and rice.

Authors:  Pavan Umate
Journal:  Plant Signal Behav       Date:  2011-03-01

5.  Restoration of lipoxin A4 signaling reduces Alzheimer's disease-like pathology in the 3xTg-AD mouse model.

Authors:  Haley C Dunn; Rahasson R Ager; David Baglietto-Vargas; David Cheng; Masashi Kitazawa; David H Cribbs; Rodrigo Medeiros
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

Review 6.  Oxidative stress and inflammation in brain aging: nutritional considerations.

Authors:  J A Joseph; B Shukitt-Hale; G Casadesus; D Fisher
Journal:  Neurochem Res       Date:  2005 Jun-Jul       Impact factor: 3.996

7.  Overexpression of 5-Lipoxygenase Worsens the Phenotype of a Mouse Model of Tauopathy.

Authors:  Phillip F Giannopoulos; Domenico Praticò
Journal:  Mol Neurobiol       Date:  2017-11-11       Impact factor: 5.590

8.  Differential contribution of lipoxygenase isozymes to nigrostriatal vulnerability.

Authors:  V P Chou; T R Holman; A B Manning-Bog
Journal:  Neuroscience       Date:  2012-10-16       Impact factor: 3.590

Review 9.  Damaging effects of a high-fat diet to the brain and cognition: a review of proposed mechanisms.

Authors:  Linnea R Freeman; Vivian Haley-Zitlin; Dorothea S Rosenberger; Ann-Charlotte Granholm
Journal:  Nutr Neurosci       Date:  2013-11-26       Impact factor: 4.994

10.  Effects of caffeic acid, rofecoxib, and their combination against quinolinic acid-induced behavioral alterations and disruption in glutathione redox status.

Authors:  Harikesh Kalonia; Puneet Kumar; Anil Kumar; Bimla Nehru
Journal:  Neurosci Bull       Date:  2009-12       Impact factor: 5.203

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.